The mechanism of hepatic cellular injury in sepsis: An in vitro study of the implications of cytokines and neutrophils in its pathogenesis

Journal of Surgical Research

Volumn 55, Issue 1, 1993, Pages 1-8

  Oka, Yoshio ^a   Murata, Atsuo ^a   Nishijima, Junichi ^a   Ogawa, Michio ^b   Mori, Takesada ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0027366245     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1993.1100     Document Type: Article

References (57)

1. Goris, R. J. A., le Boekhorst, T. P. A., Nuytinck, J. K. S., and Gimbrere, J. S. A. Multiple-organ failure: Generalized autodestructive inflammation? Arch, Surg. 120; 1109, 1985.
2. West, M. A., Keller, G. A., Hyland, B. J., and Cerra, F. B. Hepa-tocyte function in sepsis: Kupffer cells mediate a biphasic protein synthesis response in hepatocytes after exposure to endotoxin or killed Escherichia coli. Surgery 100: 416, 1986.
3. Nuytinck, J. K. S., Goris, R. J. A., Weerts, J. G. E., Schillings, P. H. M., and Stekhoven, J. H. S. Acute generalized microvascu-lar injury by activated complement and hypoxia: The basis of the adult respiratory distress syndrome and multiple organ failure? Br. J. Exp. Pathol. 67: 537, 1986.
4. Goris, R. J. A., Boekholtz, W. K. F., van Bebber, I. P. T., Nuytinck, J. K. S., and Schillings, P. H. M. Multiple-organ failure and sepsis without bacteria: An experimental model. Arch. Surg. 121: 897, 1986.
5. Schwartz, D. B., Bone, R. C., Balk, R. A., and Szidon, J. P. Hepatic dysfunction in the adult respiratory distress syndrome. Chest 95: 871, 1989.
6. Sato, T., Tanaka, J., Kono, Y., Jones, R. T., Cowley, R. A., and Trump, B. F. Hepatic cellular injury following lethal Escherichia coli bacteremia in rats. Lab. Invest. 47: 304, 1982.
7. Weiland, J. E., Davis, W. B., Holter, J. F., Mohammed, J. R., Dorinsky, P. M., and Gadek, J. E. Lung neutrophils in the adult respiratory distress syndrome. Clinical and pathophysiologic significance, Am. Rev. Respir. Dis. 133: 218, 1986.
8. Swank, D. W., and Moore, S. B. Roles of the neutrophil and other mediators in adult respiratory distress syndrome. Mayo Clin. Proc. 64: 1118, 1989.
9. Wiener-Kronish, J. P., Gropper, M. A., and Matthay, M. A. The adult respiratory distress syndrome: Definition and prognosis, pathogenesis and treatment. Br. J. Anaesth. 65: 107, 1990.
10. Weiss, S. J. Tissue destruction by neutrophils. N. Engl. J. Med. 320: 365, 1989.
11. Hesse, D. G., Tracey, K. J., Fong, Y., Manogue, K. R., Palladino, M. A., Jr., Cerami, A., Shires, T., and Lowry, S. F. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstetr. 166: 147, 1988.
12. Michie, H. R., Manogue, K. R., Spriggs, D. R., Revhaug, A., O'Dwyer, S., Dinarello, C. A., Cerami, A., Wolff, S. M., and Wil-more, D. W. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318: 1481, 1988.
13. Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey III, T. J., Zentella, A., Albert, J. D., Shires, T., and Cerami, A. Shock and tissue injury induced by recombinant human cachectin. Science 234: 470, 1986.
14. Johnson, A., and Malik, A. B. Effect of granulocytopenia on ex-travascular lung water content after microembolization. Am. Rev. Respir. Dis. 122: 561, 1980.
15. Heflin, A. C., Jr., and Brigham, K. L. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J. Clin. Invest. 68: 1253, 1981.
16. Flick, M. R., Perel, A., and Staub, N. C. Leukocytes are required for increased lung microvascular permeability after microembolization in sheep. Circ. Res. 48: 344, 1981.
17. Shasby, D. M., Fox, R. B., Harada, R. N., and Repine, J. E. Reduction of the edema of acute hyperoxic lung injury by granulocyte depletion. J. Appl. Physiol. 52: 1237, 1982.
18. Mallick, A. A., Ishizaka, A., Stephens, K. E., Hatherill, J. R., Tazelaar, H. D., and Raffin, T. A. Multiple organ damage caused by tumor necrosis factor and prevented by prior neutrophil depletion. Chest 95: 1114, 1989.
19. Murata, A., Ogawa, M., Uda, K., Matsuura, N., Watanabe, Y., Baba, T., and Mori, T. Release of pancreatic secretory trypsin inhibitor from human hepatoblastoma cells on stimulation with cytokines. Life Sci. 43: 1233, 1988.
20. Yasuda, T., Ogawa, M., Murata, A., Oka, Y., Uda, K., and Mori, T. Response to IL-6 stimulation of human hepatoblastoma cells: Production of pancreatic secretory trypsin inhibitor. Biochem. J. Hoppe-Seykr’s 371(Suppl.): 95, 1990.
21. Jönson, B.-M., Löffler, C., and Ohlsson, K. Human granulocyte elastase is inhibited by the urinary trypsin inhibitor. Hoppe-Seyler’s Z. Physiol. Chem. 363(Suppl.): 1167, 1982.
22. Ogawa, M., NishLbe, S., Mori, T., and Neumann, S. Effect of human trypsin inhibitor on granulocyte elastase activity. Res. Commun. Chem. Pathol. Pharmacol. 55: 271, 1987.
23. Ohnishi, H., Kosuzume, H., Ashida, Y., Kato, K., and Honjo, I. Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis. Dig. Dis. Sci. 29: 26, 1984.
24. Kashimoto, S., Nakagomi, M., Nonaka, A., and Kumazawa, T. The effects of Ulinastatin on cardiac and hepatic energy metabolism in rats subjected to hypovolemic shock. J. Anesth. 4: 40, 1990.
25. Doi, I. Establishment of a cell line and its clonal sublines from a patient with hepatoblastoma. Gann 67: 1, 1976.
26. Neumann, S., Gunzer, G., Hennrich, N., and Lang, H. “PMN-elastase assay”: Enzyme immunoassay for human polymorphonuclear elastase in complex with a 1-proteinase inhibitor. J. Clin. Chem. Clin. Biochem. 22: 693, 1984.
27. Wroblewski, F., and Ladue, J. S. Lactic dehydrogenase activity in blood. Proc. Soc. Exp. Biol. Med. 90: 210, 1955.
28. Mackiewicz, A., Speroff, T., Ganapathi, M. K., and Kushner, I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J. Immunol. 146: 3032, 1991.
29. Doumas, B. T., Watson, W. A., and Biggs, H. G. Albumin standards and the measurement of serum albumin with bromcresol green. Clin. Chim. Acta 31: 87, 1971.
30. Kitahara, T., Takatsuka, Y., Fujimoto, K., Tanaka, S., Ogawa, M., and Kosaki, G. Radioimmunoassay for human pancreatic secretory trypsin inhibitor: Measurement of serum pancreatic secretory trypsin inhibitor in normal subjects and subjects with pancreatic diseases. Clin. Chim. Acta 103: 135, 1980.
31. Damas, P., Reuter, A., Gysen, P., Demonty, J., Lamy, M., and Franchimont, P. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17: 975, 1989.
32. Murata, A., Ogawa, M., Yasuda, T., Nishijima, J., Oka, Y., Oh-machi, Y., Hiraoka, N., Niinobu, T., Uda, K., and Mori, T. Serum interleukin 6, C-reactive protein and pancreatic secretory trypsin inhibitor (PSTI) as acute phase reactants after major thor-aco-abdominal surgery. Immunol. Invest. 19: 271, 1990.
33. Cerami, A., and Beutler, B. The role of cachectin/TNF in endo-toxic shock and cachexia. Immunol. Today 9: 28, 1988.
34. Ramila, P., and Epstein, L. B. Tumor necrosis factor as an immune modulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature 323: 86, 1986.
35. Jirik, F. R., Podor, T. J., Hirano, T., Kishimoto, T., Loskutoff, D. J., Carson, D. A., and Lotz, M. Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J. Immunol. 142: 144, 1989.
36. Elias, J. A., and Lentz, V. IL-1 and tumor necrosis factor syner-gistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J. Immunol. 145: 161, 1990.
37. Furuta, R., Yamagishi, J., Kotani, H., Sakamoto, F., Fukui, T., Matsui, Y., Sohmura, Y., Yamada, M., Yoshimura, T., Larsen, C. G., Oppenheim, J. J., and Matsushima, K. Production and characterization of recombinant human neutrophil chemotactic factor. J. Biochem. 106: 436, 1989.
38. Baggiolini, M., Walz, A., and Kunkel, S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84: 1045, 1989.
39. Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T., and Sato, J. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res. 42: 3858, 1982.
40. Nakabayashi, H., Taketa, K., Yamane, T., Oda, M., and Sato, J. Hormonal control of a-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium. Cancer Res. 45: 6379, 1985.
41. Ogawa, M., Matsuda, K., Shibata, T., Matsuda, Y., Ukai, T., Ohta, M., and Mori, T. Elevation of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with serious injury. Res. Commun. Chem. Pathol. Pharmacol. 50: 259, 1985.
42. Matsuda, K., Ogawa, M., Shibata, T., Nishibe, S., Miyauchi, K., Matsuda, Y., and Mori, T. Postoperative elevation of serum pancreatic secretory trypsin inhibitor. Am. J. Gastroenterol. 80:694, 1985.
43. Ogawa, M. Pancreatic secretory trypsin inhibitor as an acute phase reactant. Clin. Biochem. 21: 19, 1988.
44. Ogawa, M., Shibata, T., Niinobu, T., Uda, K., Takata, N., and Mori, T. Serum pancreatic secretory trypsin inhibitor (PSTI) in patients with inflammatory diseases. Adv. Exp. Med. Biol. 240: 505, 1988.
45. Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S., Nakajima, K., Koyama, K., Iwa-matsu, A., Tsunasawa, S., Sakiyama, S., Matsui, H., Takahara, Y., Taniguchi, T., and Kishimoto, T. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73, 1986.
46. Le, J., and Vilcek, J. Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest. 61: 588, 1989.
47. Blackwell, J. B. The effect on the liver of sensitized rats of intravenous injection of antigen. J. Pathol. Bacterial. 90: 259, 1965.
48. Coalson, J. J., Archer, L. T., Hall, N. K., Kern, J. D., Benjamin, B. A., Beller-Todd, B., and Hinshaw, L. B. Prolonged shock in the monkey following live E. coli organism infusion. Circ. Shock 6: 343, 1979.
49. Balis, J. U., Paterson, J. F., Shelley, S. A., Larson, C. H., Fareed, J., and Gerber, L. I. Glucocorticoid and antibiotic effects on hepatic microcirculation and associated host responses in lethal gram-negative bacteremia. Lab. Invest. 40: 55, 1979.
50. Havemann, K., and Gramse, M. Physiology and pathophysiology of neutral proteinases of human granulocytes. Adv. Exp. Med. Biol. 167: 1, 1984.
51. Halliwell, B., and Gutteridge, J. M. C. Free Radicals in Biology and Medicine. New York: Oxford Univ. Press, 1989.
52. Aaron, J. Elastase in tissue injury. Ann. Rev. Med. 36: 207, 1985.
53. Klebanoff, S. J., Vadas, M. A., Harlan, J. M., Sparks, L. H., Gamble, J. R., Agosti, J. M., and Waltersdorph, A. M. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136: 4220, 1986.
54. Anderson, B. O., Poggetti, R. S., Shanley, P. F., Bensard, D. D., Pitman, J. M., Nelson, D. W., Whitman, G. J. R., Banerjee, A., and Harken, A. H. Primed neutrophils injure rat lung through a platelet-activating factor-dependent mechanism. J. Surg. Res. 50: 510, 1991.
55. Weiss, S. J., Curnutte, J. T., and Regiani, S. Neutrophil-mediated solubilization of the subendothelial matrix: Oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J. Immunol. 136: 636, 1986.
56. Andus, T., Bauer, J., and Gerok, W. Effects of cytokines on the liver. Hepatology 13: 364, 1991.
57. Holman, J. M., Jr., and Saba, T. M. Hepatocyte injury during post-operative sepsis: Activated neutrophils as potential mediators. J. Leukoc. Biol. 43: 193, 1988.